Collegium Pharmaceutical (COLL) EBIT Margin (2016 - 2026)
Collegium Pharmaceutical's EBIT Margin came in at 1.85% for Q2 2026, down 16.82 percentage points from 18.67% a year earlier and down 14.12 percentage points from the prior quarter.
Powered by 
Analysis
Collegium Pharmaceutical (COLL) EBIT Margin (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Collegium Pharmaceutical reported EBIT Margin of 19.48%, up 1.13 percentage points year-over-year; for FY2025, it came in at 23.01%, down 3.89 percentage points from FY2024.
- EBIT Margin carries a five-year change of +4.88 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was 26.91% in FY2024 (-2.55 pp), 29.46% in FY2023 (+22.28 pp), 7.18% in FY2022 (+0.81 pp) and 6.37% in FY2021 (-11.77 pp).
- The Q2 2026 figure represents the lowest quarterly EBIT Margin since Q1 2022.
- Year-over-year, EBIT Margin increased in three of the last eight quarters, with an average year-over-year change of -7.99 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q4 2022 (a gain of 133.78 percentage points), and the weakest in Q4 2021 (a drop of 144.37 percentage points).
- Business Quant data shows COLL's EBIT Margin at 15.97% (Q1 2026), 29.57% (Q4 2025) and 29.66% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Collegium Pharmaceutical | 735.44 Mn | -488.33 Mn | 110.29 Mn | 1.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.85% |
| Mar 31, 2026 | 15.97% |
| Dec 31, 2025 | 29.57% |
| Sep 30, 2025 | 29.66% |
| Jun 30, 2025 | 18.67% |
| Mar 31, 2025 | 12.20% |
| Dec 31, 2024 | 20.95% |
| Sep 30, 2024 | 21.87% |
| Jun 30, 2024 | 32.68% |
| Mar 31, 2024 | 34.14% |
| Dec 31, 2023 | 41.20% |
| Sep 30, 2023 | 32.93% |
| Jun 30, 2023 | 26.29% |
| Mar 31, 2023 | 17.01% |
| Dec 31, 2022 | 9.07% |
| Sep 30, 2022 | 16.11% |
| Jun 30, 2022 | 8.99% |
| Mar 31, 2022 | -11.96% |
| Dec 31, 2021 | -124.71% |
| Sep 30, 2021 | 17.95% |
API Access
Collegium Pharmaceutical EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=COLL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "COLL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=COLL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();